Yield10 Bioscience Other Current Liabilities

Yield10 Bioscience posts a other current liabilities of $2.8M as of June 2024. That compares with $1.4M in the prior-year period — up 105.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Yield10 Bioscience's other current liabilities was $1.4M. The latest reading is $2.8M — a 105.4% year-over-year increase (period ending June 2024). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Yield10 Bioscience's financial statement story. At $2.8M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for YTEN's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Yield10 Bioscience's other metric pages and overview cover the third.

Judging Yield10 Bioscience against Consumer Discretionary peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Discretionary are more comparable, which makes gaps in other current liabilities easier to interpret. Start with $2.8M here, then scan peer and history charts to see if the gap is persistent.